Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- In-licensing
- View
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases.
Mechanism of action
Small molecules with innovative mechanism of action
Full description
Zambon's R&D core competences range from hit-to-lead
optimization up to full drug development.
Its Lead Optimization Unit is capable to quickly bridge the
gap between hit discovery and pre-clinical development and
to
reduce the risk of failures in clinical development.
Zambon's R&D wants to become a valuable partner for all
those Drug Discovery companies that want to add value to
their lead molecules and see their candidate drugs enter
riskless into development.
Development status
Early Stage
Type of business relationship sought
Companies having proprietary hits/lead compounds for
innovative targets or proprietary targets and screening
capabilities, will find a dynamic group capable to either
optimize existing compounds or discover new hits.
Zambon business model is based on collaboration aiming at
bringing values to all partners. Roles and responsibilities can
be flexibly arranged to obtain a successful and well-balanced
relationship among partners.
Licensing contact
Dr Salvatore Sturniolo
Licensing Manager
Licensing & Business Development
Licensing Manager
Licensing & Business Development
More information
For more information about the product please visit website.
Company details
Zambon Group
Zambon Group is a privately-held multinational pharmaceutical company that in-licenses pharmaceutical products from the discovery to late stage development or already on the market.
Zambon Group is a privately-held multinational pharmaceutical company that in-licenses pharmaceutical products from the discovery to late stage development or already on the market.
Related reports
Are you looking for reports related to this particular subject. Our Reports section is the best place to start.
Related items
- Seeking development opportunities with novel delivery technologies for oral, topical and transdermal products
- Seeking opportunities for consumer healthcare products and molecules with Rx-to-OTC switch potential
- Analgesics, anaesthetics and palliative care products.
- NCEs, new patented formulations and products
- OTC Microbicidal products
Related categories
- Industry sector
- Pharmaceutical
- Drug discovery / High throughput screening
- Pharmaceutical
- Pharmaceutical / Prescription
- Therapeutic target
- Allergy
- Allergy / Allergic rhinitis (hay fever)
- Allergy / Allergies (other)
- Allergy / Allergy, skin
- Cardiovascular / Vascular / Atherosclerosis
- Cardiovascular / Cardiovascular disorder (other) / Hemorrhoidal
- Cardiovascular / Vascular / Hypertension
- Cardiovascular / Cardiovascular disorder (other) / Varicose vein
- Cardiovascular / Blood composition / Hyperlipidemia
- Cardiovascular / Thrombotic disorders / Peripheral vascular disease
- Cardiovascular / Blood composition / Dyslipidemia
- Cardiovascular / Blood composition / Hypercholesterolemia
- Cardiovascular / Blood composition / Hypertriglyceridemia
- Cardiovascular / Vascular / Hypotension
- Cardiovascular / Thrombotic disorders / Peripheral arterial disease
- Cardiovascular / Thrombotic disorders / Platelet aggregation
- Cardiovascular / Cardiovascular disorder (other) / Ulcer, pressure
- Cardiovascular / Cardiovascular disorder (other) / Ulcer, venous
- Central Nervous System / Age-related disorders (other)
- Central Nervous System / Pain / Pain management general
- Central Nervous System / Psychiatric / Anxiety
- Central Nervous System / CNS (other) / Diabetic neuropathy
- Central Nervous System / Neurological / Emesis
- Central Nervous System / Neurological / Insomnia
- Central Nervous System / Pain / Pain, back upper/lower
- Central Nervous System / Pain / Pain, chronic
- Central Nervous System / Pain / Pain, inflammatory
- Central Nervous System / Pain / Pain, neuropathic
- Central Nervous System / CNS (other) / Sexual dysfunction
- Central Nervous System / CNS (other) / Smoking cessation
- Dermatological
- Dermatological / Skin infection (other)
- Dermatological / Bacterial infection
- Dermatological / Fungal infection
- Gastrointestinal
- Genito-urinary
- Genito-urinary / Gender related medicine female / Gynecological disorder (other)
- Genito-urinary / Urinary / Urinary tract disorder (other)
- Genito-urinary / Gender related medicine female / Pelvic inflammatory disease
- Genito-urinary / Sexually transmitted diseases / Sexually transmitted diseases (other)
- Genito-urinary / Genito-urinary other / Reproductive health (other)
- Genito-urinary / Urinary / Urinary tract infection
- Genito-urinary / Gender related medicine female / Women's health (other)
- Genito-urinary / Sexually transmitted diseases / Venereal disease (other)
- Infectious diseases / Diseases / Infection, fungal (other)
- Infectious diseases / Diseases / Diarrhea, bacterial
- Metabolism
- Metabolism / Obesity
- Musculoskeletal
- Respiratory
- Respiratory / Asthma
- Respiratory / Asthma, bronchospasm
- Respiratory / Respiratory disorder (other)
- Respiratory / Allergy, respiratory
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us